{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:04:24Z","timestamp":1791900264863,"version":"4.3.4"},"reference-count":71,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2016,9,4]],"date-time":"2016-09-04T00:00:00Z","timestamp":1472947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Development Research"],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>\n<jats:table-wrap position=\"anchor\">\n\n<jats:table frame=\"hsides\">\n<jats:col\/>\n<jats:tbody>\n<jats:tr>\n<jats:td>Preclinical Research<\/jats:td>\n<\/jats:tr>\n<\/jats:tbody>\n<\/jats:table>\n<\/jats:table-wrap><\/jats:p><jats:p>S\u2010adenosyl methionine (SAM) is a major methyl donor and as such exerts its influence on CNS function through methylation reactions, such as methylation of several catecholamine moiety\u2010containing neurotransmitters, epigenetic changes through methylation of DNA, RNA, RNA\u2010binding proteins and histones, and phospholipid methylation. Based on available evidence, SAM is currently recommended as a next\u2010step (second\u2010line) treatment option following inadequate treatment response to a first\u2010line antidepressant. It shows significant promise in the treatment of pediatric and perinatal depression, as well as Alzheimer's disease, but to make this a recommendation further clinical trials are needed. SAM is safe to use in most patients, but is contraindicated in those with bipolar disorder. Concerns considering the possible increase of homocysteine levels (and cardiovascular complications) due to long\u2010term SAM therapy need to be further addressed in clinical trials taking into account individual`s ability to metabolize homocysteine and his\/her folate status. Drug Dev Res 77 : 336\u2013346, 2016. \u00a9 2016 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/ddr.21345","type":"journal-article","created":{"date-parts":[[2016,9,4]],"date-time":"2016-09-04T23:53:48Z","timestamp":1473033228000},"page":"346-356","source":"Crossref","is-referenced-by-count":28,"title":["S\u2010Adenosyl Methionine in the Therapy of Depression and Other Psychiatric Disorders"],"prefix":"10.1002","volume":"77","author":[{"given":"Nata\u0161a","family":"Karas Ku\u017eeli\u010dki","sequence":"first","affiliation":[{"name":"Chair of Clinical Biochemistry, Faculty of Pharmacy University of Ljubljana, Askerceva 7 1000 Ljubljana Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,9,4]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(76)90008-X"},{"key":"e_1_2_10_3_1","unstructured":"AHRQ(Agency for Healthcare Research and Quality) USDfhahs.2002. S\u2010Adenosyl\u2010L\u2010Methionine for tratment of depression osteoarthritis and liver disease. AHFQ Evidence Report 64.http:\/\/archive.ahrq.gov\/clinic\/epcsums\/samesum.htm. Retrieved June 1 2016."},{"key":"e_1_2_10_4_1","first-page":"235","article-title":"Sugli effetti clinici della s\u2010adenosil\u2010metionina (SAMe) nelle sindromi depressive","volume":"19","author":"Barberi A","year":"1978","journal-title":"Minerva Psichiatr"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.9.1110"},{"key":"e_1_2_10_6_1","article-title":"Oral s\u2010adenosylmethionine in the treatment of depression: a double\u2010blind comparison with desipramine","author":"Bell MB","year":"1990","journal-title":"Study Report."},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.4161\/epi.7.1.18688"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0560-3"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2012.12.001"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.53.12.1096"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1994.tb05403.x"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198608000-00005"},{"key":"e_1_2_10_13_1","first-page":"305","article-title":"Treatment of depression in rheumatoid arthritic patients. A comaprison of S\u2010adenosylmethionine (Samyr) and placebo in a double\u2010blind study","volume":"24","author":"Caruso I","year":"1987","journal-title":"Clin Trials J"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91360-6"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-010-0054-5"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/NMD.0b013e31823fafdf"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115581093"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.2190\/1GRB-RKBH-NB2A-PPWR"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(05)80424-2"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2013.08.007"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/76.5.1172S"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S77766"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/15257770.2013.774012"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1992.tb03223.x"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-006-0229-8"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.174268"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.24.16.1501.50943"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-012-0831-x"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2016.00089"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNR.0b013e32800fefd7"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep00677"},{"key":"e_1_2_10_32_1","first-page":"306","article-title":"S\u2010adenosylmethionine in depression. A literature review and preliminary report","volume":"25","author":"Janicak PG","year":"1988","journal-title":"Ala J Med Sci"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.147.5.591"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-012-1623-y"},{"key":"e_1_2_10_35_1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-2011-111025","article-title":"Dietary supplementation with S\u2010adenosyl methionine delayed amyloid\u2010beta and tau pathology in 3xTg\u2010AD mice","volume":"28","author":"Lee S","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.04.059"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1042\/BST0340330"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5795.297"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9861(02)00030-9"},{"key":"e_1_2_10_40_1","first-page":"243","article-title":"Comparison between the antidepressant activity and of S\u2010adenosylmethionine (SAMe) and that of some tricyclic drugs","volume":"33","author":"Miccoli L","year":"1978","journal-title":"Acta Neurol (Napoli)"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07139"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13m08591"},{"key":"e_1_2_10_43_1","first-page":"417","article-title":"[Study of the antidepressive effects of a biological transmethylating agent (S\u2010adenosyl\u2010methione or SAM)]","volume":"49","author":"Monaco P","year":"1979","journal-title":"Riv Neurol"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.67031328.x"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000064"},{"key":"e_1_2_10_46_1","first-page":"151","article-title":"SAMe versus placebo: a double blind comparison in major depressive disorders","volume":"32","author":"Muscettola G","year":"1982","journal-title":"Adv Biochem Psychopharmacol"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.2001.280.2.E280"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.04984.x"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-003-0085-2"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.09081198"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2012.01346.x"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00056.2014"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-142499"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1159\/000288642"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2016.15091228"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.03.041"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1549928"},{"key":"e_1_2_10_58_1","first-page":"359","article-title":"Confronto clinico in doppio cieco della SAMe versus clorimipramina nelle sindromi depressive","volume":"102","author":"Scarzella R","year":"1978","journal-title":"Rivisita Sperimentale Di Feniatria"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-004-0396-9"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M112.019364"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2006.08.003"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2008-13107"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2008.08.004"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-198704000-00001"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2008.0402"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.12.2099"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2012.00092"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024287"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-8-25"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113507640"},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2015.07.024"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2011.12.007"}],"container-title":["Drug Development Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fddr.21345","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fddr.21345","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ddr.21345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T16:11:54Z","timestamp":1760371914000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/ddr.21345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,4]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1002\/ddr.21345"],"URL":"https:\/\/doi.org\/10.1002\/ddr.21345","archive":["Portico"],"relation":{},"ISSN":["0272-4391","1098-2299"],"issn-type":[{"value":"0272-4391","type":"print"},{"value":"1098-2299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,4]]}}}